Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134083) titled 'Comparison of semeglutide and semeglutide plus sodium-glucose cotransporter-2 inhibitors on participants with type 2 diabetes and MAFLD' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiamen Humanity Hospital
Condition:
type 2 diabetes participants with metabolic dysfunction-associated fatty liver disease
Intervention:
intervention group:Semaglutide + sodium-glucose cotransporter-2 inhibitors
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-06-02
Target Sample Size: intervention group:35;control group:35;
Countries of Recruitment:
Chi...